Primary Care Clinics in Tell City, IN Accepting Medicare
11 Primary Care Clinics found. Showing 1 - 11
 Tell City Clinic Family Medicine Medicare: Medicare Enrolled Practice Location: 109 Us Highway 66 E, Tell City, IN 47586 Phone: 812-547-3447 Fax: 812-547-9543 |
Waupaca Foundry, Tell City General Practice Medicare: Not Enrolled in Medicare Practice Location: 1001 Main Street, Tell City, IN 47586 Phone: 812-608-4697 |
Thomas P. Bailey, Md, Llc Family Medicine Medicare: Medicare Enrolled Practice Location: 421 7th St, Tell City, IN 47586 Phone: 812-547-9663 Fax: 812-547-6830 |
Leitchfield Primary Care Pllc Family Medicine Medicare: Medicare Enrolled Practice Location: 8885 State Road 237, Tell City, IN 47586 Phone: 812-547-7011 |
Gene E Ress M.d. Psc Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2127 Tell St, Tell City, IN 47586 Phone: 812-971-8222 Fax: 812-359-4481 |
Pcmh Provider Clinics Family Medicine Medicare: Medicare Enrolled Practice Location: 8885 State Road 237, Tell City, IN 47586 Phone: 812-547-0135 |
Dr Rogan & Associates Pc Clinic/Center Medicare: Medicare Enrolled Practice Location: 8475 Dauby Ln, Tell City, IN 47586 Phone: 812-547-1377 Fax: 812-547-3695 |
13th Street Clinic Family Medicine Medicare: Medicare Enrolled Practice Location: 148 13th St, Suite B, Tell City, IN 47586 Phone: 812-547-3447 |
Marcrum Family Healthcare Llc Family Medicine Medicare: Medicare Enrolled Practice Location: 421 7th Street, Tell City, IN 47586 Phone: 812-547-6830 |
Fast Pace Medical Clinic Pllc Clinic/Center - Rural Health Medicare: Medicare Enrolled Practice Location: 211 E State Hwy 66, Tell City, IN 47586 Phone: 812-772-4380 |
Kleeman Family Medicine Llc Family Medicine Medicare: Medicare Enrolled Practice Location: 421 7th St, Tell City, IN 47586 Phone: 812-547-9663 Fax: 812-547-1300 |
News Archive
Boehringer Ingelheim's interim data from Phase II HCV clinical collaboration with Presidio Pharmaceuticals accepted for presentation at AASLD
Boehringer Ingelheim today announced that interim data from its Phase II hepatitis C (HCV) clinical collaboration with Presidio Pharmaceuticals have been accepted for presentation as a late breaker poster at the 64th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD), taking place 1-5 November in Washington, D.C. (1) The poster presentation will be on Monday 4 November.
Goodtherapy.Org receives BBB Accreditation
Today, GoodTherapy.org announces its commitment to marketplace ethics by earning Accreditation with Better Business Bureau. As a BBB Accredited Business, GoodTherapy.org has met BBB's Code of Business Practices and has agreed to maintain honest and reliable business practices.
FDA approval for VNS Therapy will help people with epilepsy
The U.S. Food and Drug Administration's recent approval of Vagus Nerve Stimulation Therapy for treatment of chronic depression provides a novel single-treatment option for two major symptoms suffered by people with epilepsy.
New therapy shows potential for treating Duchenne muscular dystrophy
Researchers at the University of Minnesota Medical School have discovered a new therapy that shows potential to treat people with Duchenne muscular dystrophy, a fatal disease and the most common form of muscular dystrophy in children.
Three scientific posters featuring Zenvia to be presented at AAN Annual Meeting
AVANIR Pharmaceuticals, Inc., today announced it will present three scientific posters featuring detailed Zenvia™ (dextromethorphan/quinidine) safety and efficacy data from the double-blind phase and the open label extension of the Phase III confirmatory STAR trial at the American Academy of Neurology Annual Meeting in Toronto, Canada, taking place April 10 - 17, 2010.
› Verified 6 days ago